Epiretinal Membrane Clinical Trial
Official title:
Topical Use of Corticosteroid to Prevent Epiretinal Membrane Formation in Eyes With Retinal Tear Undergoing Laser Retinopexy: a Pilot Prospective Clinical Study
In this prospective randomized controlled double blind pilot clinical study, we aim to assess whether administration of a topical corticosteroid would attenuate epiretinal membrane formation following development of retinal tears treated with laser retionpexy.
Epiretinal membrane (ERM) is a frequent, sight-threatening eye condition occurring in 1.02% - 28.9% of eyes in persons aged 40 years or older. [1] While often idiopathic in nature, ERM formation has been associated with retinal tears, possibly due to a breakdown of the blood-retinal barrier [1-3]. Pathological analysis of ERM content shows inflammatory mediators such as cytokines, growth factors and interleukins, which can promote fibroblast remodelling that leads to a contractile scar formation on the retinal surface. [1, 4-8] For this reason, ERM formation has been suggested to be an aberrant tissue repair or wound-healing process driven by inflammatory reactions. Since corticosteroids inhibit the inflammatory cascade and fibroblast transdifferentiation, administration of a corticosteroid following retinal tears should theoretically reduce the risk of ERM formation. [9-10] In this study, we aim to assess whether administration of a topical corticosteroid would attenuate ERM formation following laser retinopexy of retinal tears. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03332758 -
Inflammasomes in Cell Death in FTMH, ERM, and RRD
|
||
Active, not recruiting |
NCT04130841 -
Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Terminated |
NCT01532765 -
Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal
|
N/A | |
Completed |
NCT01474655 -
Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal
|
N/A | |
Active, not recruiting |
NCT04120311 -
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
Completed |
NCT04445142 -
Fovea ERM After Fovea-sparing ILM Peeling
|
||
Recruiting |
NCT01701518 -
A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes
|
N/A | |
Completed |
NCT01627977 -
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
|
Phase 3 | |
Completed |
NCT01771939 -
Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes
|
N/A | |
Completed |
NCT00408720 -
Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
|
N/A | |
Completed |
NCT05171621 -
Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery
|
||
Active, not recruiting |
NCT04306718 -
Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study
|
N/A | |
Recruiting |
NCT01985490 -
Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane
|
N/A | |
Completed |
NCT01238393 -
Treatment of Epiretinal Membranes With Ranibizumab
|
N/A | |
Terminated |
NCT00333060 -
Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
|
Phase 2 | |
Completed |
NCT05287269 -
Ocular Coherence Tomography During Cataract Assessment
|
||
Recruiting |
NCT05138315 -
Quantification of Metamorphopsia in Patients With Epiretinal Membranes
|
N/A | |
Recruiting |
NCT03661593 -
Aniseikonia in Epiretinal Membrane Patients
|
N/A | |
Completed |
NCT03457584 -
Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling
|
N/A |